Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on asymmetric synthesis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Advanced synthesis of Simeprevir intermediate via patent CN105348144B offers high purity and safer manufacturing for global pharmaceutical supply chains.
Patent CN113930415A details a novel enzymatic route for antifungal intermediates, offering high stereoselectivity and simplified purification for scalable manufacturing.
Patent CN110508323B details a water-phase Henry reaction using a recyclable thermosensitive chiral copper catalyst, offering high enantioselectivity and simplified downstream processing for pharmaceutical intermediates.
Patent CN105017269A reveals a novel organocatalytic route for high-purity chiral spiro oxindole derivatives, offering significant cost reduction and scalable manufacturing advantages for pharmaceutical supply chains.
Patent CN115557873A details a novel asymmetric synthesis for Brivaracetam methyl ester impurity, offering high purity and cost-effective production for quality control standards.
Advanced Lewis acid-catalyzed synthesis of Ezetimibe intermediates offers high purity and mild conditions, ensuring cost-effective supply for cardiovascular drug manufacturing.
Patent CN102399139B details a scalable resolution method for Shikonin and Alkannin. Achieve >99% ee with cost-effective raw materials for API manufacturing.
Novel asymmetric synthesis method for ubenimpam intermediate avoiding HPLC resolution and expensive metals for cost-effective supply chain solutions.
Novel asymmetric acetal method for (1R,5S)-3-ethylbicyclo[3.2.0]hept-3-en-6-one synthesis. High ee%, low cost, scalable process for API manufacturing.
Novel telescoping route for DPP1 inhibitor intermediate ensures high purity and scalable production for global pharmaceutical supply chains seeking cost reduction.
Patent CN101066924B reveals a streamlined chemical synthesis for Orlistat intermediates, offering high purity and scalable production for pharmaceutical manufacturers.
Novel 10-step synthesis for Lobeline avoiding expensive catalysts. High yield, mild conditions. Reliable pharmaceutical intermediate supplier for global markets.
Patent CN101892273B reveals immobilized lipase Lipozyme TLIM enables green, high-yield asymmetric Michael addition, offering cost reduction in pharmaceutical intermediate manufacturing.
Novel asymmetric synthesis method for high-purity pharmaceutical intermediates ensuring supply chain reliability and cost reduction.
Patent CN101801984A details novel chiral phosphoramides and N-phosphonimines. Discover stable alternatives to N-sulfinylimines for cost-effective asymmetric synthesis.
Patent CN103145540B reveals efficient synthesis for statin intermediates. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing globally.
Novel asymmetric synthesis of Florfenicol Intermediate V reduces waste and cost. Reliable supplier for veterinary API intermediates with scalable chiral technology.
Novel route for ETP natural product Epicoccin G using photo-oxidation and dimerization. Cost-effective scale-up for pharmaceutical intermediates.
Novel patent CN114751853B enables safer synthesis of key antiviral intermediates. Achieve high purity and yield without toxic cyanide. Reliable supply chain partner.
Patent CN103483201A details a novel asymmetric synthesis of (R)-2-methyl-4-nitro-1-butanol, eliminating racemic resolution for significant cost reduction and improved supply chain efficiency.